Two Sigma Advisers’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
VI
MF
FLAM
AAM
KLCMU
RSCM
Two Sigma Advisers's XENT Position: Q4 2021 in Review
Two Sigma Advisers sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 336,800 shares — an estimated $9.16M sold.
Two Sigma Advisers first reported a position in XENT in Q2 2015 and held it in 18 quarters. The position peaked at $9.16M in Q3 2021. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.
- Two Sigma Advisers reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
- Two Sigma Advisers sold 336,800 Intersect ENT, Inc shares in Q4 2021, an estimated $9.16M.
- Two Sigma Advisers first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 18 quarters.
- Two Sigma Advisers's Intersect ENT, Inc position peaked at $9.16M in Q3 2021.
- 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.
Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.